MedPath

Effect of Early Education on the Observance of CPAP Treatment

Not Applicable
Completed
Conditions
Sleep Apnea Syndrome
Interventions
Other: Control group
Behavioral: Coaching group
Registration Number
NCT02657304
Lead Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Brief Summary

Sleep apnea (SA) affects more than 4% from general population and is largely underdiagnosed. SA can increase the occurrence of cardiovascular, endocrine and metabolic events (particularly stroke, diabetes \& obesity). CPAP is currently the Gold Standard treatment of SA and to prevent these events, with a major clinical benefit, long term adherence to CPAP is a significant problem where a significant rate of rejection and abundance after 6 months of treatment.

Detailed Description

Sleep apnea (SA) affects more than 4% from general population (20% of people over 65 years) and is largely underdiagnosed, it can be rise up by some factors such as: obesity, male gender. Sleep Apnea can increase the occurrence of cardiovascular, endocrine and metabolic events (particularly stroke, diabetes \& obesity). CPAP is currently the Gold Standard treatment of SA and to prevent these events, with a major clinical benefit, long term adherence to CPAP is a significant problem where a significant rate of rejection and abundance after 6 months of treatment.

The investigators hypothesize that an early education and information of SA (in the first 2 weeks after diagnosis of SA and one telephonic call/month while 5 months) would allow to increase significantly the optimal observance of CPAP (\> 5 h/night).

Thus, in this study, we will compare evolution of the observance of CPAP (h/night), of the apnea hypopnea index (AHI), patient knowledge of their SA and its deleterious health consequences in an early education and information during five months against a control group receiving only usual care (standard).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
120
Inclusion Criteria
  • Patients affiliated or entitled to a French medical insurance
  • Patients of both gender, aged from 18 to 80 years
  • Patients with AHI > 30/hour or between 15 & 30/h with Sleep Fragmentation Index (SFI) of more than 10/h
  • Signature of consent
Exclusion Criteria
  • Known diseases which contraindicated used of CPAP treatment

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control groupControl groupPPC
Coaching groupCoaching groupPPC + Coaching
Primary Outcome Measures
NameTimeMethod
Observance5 months

Percentage of patients with a mean duration of observance of more than 5h/night after five months of follow-up in the coached and the control groups

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Chu Saint-Etienne

🇫🇷

St Etienne, France

© Copyright 2025. All Rights Reserved by MedPath